Role of peripheral blood minimum residual disease at day 8 of induction therapy in high-risk pediatric patients with acute lymphocytic leukemia

Risk stratification and treatment intensification, based on minimal residual disease (MRD) mensurement, changed the prognosis of pediatric patients with acute lymphocytic leukemia (ALL). The main aim of this study was to investigate whether peripheral blood (PB) MRD measurement at day 8 (D8) could p...

Descripción completa

Detalles Bibliográficos
Autores principales: Salina, Thais Ditolvo da Costa, Ferreira, Yvelise Antunes, Alves, Eliana Brasil, Ferreira, Cristina Motta, De Paula, Erich Vinícius, Mira, Marcelo Távora, Passos, Leny da Mota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985643/
https://www.ncbi.nlm.nih.gov/pubmed/27526794
http://dx.doi.org/10.1038/srep31179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985643/
https://www.ncbi.nlm.nih.gov/pubmed/27526794
http://dx.doi.org/10.1038/srep31179

Ejemplares similares